Hasil Pencarian - Matthew Gumbleton
- Menampilkan 1 - 3 hasil dari 3
-
1
-
2
A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the s... oleh Matthew Gumbleton, Stephanie Allan, Hannah Conway, Kenneth Boucher, James Marvin, Josiah Hawks, William Burnett, Matthew Van Brocklin, Jonathan Whisenant, Glynn Gilcrease, Sumati Gupta
Diterbitkan 2023-02-01
Artikel -
3